168 results on '"Cobo, S."'
Search Results
2. Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer
3. SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
4. 237MO TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy without immunotherapy
5. Ecology and recovery plans for the four Spanish endangered endemic butterfly species
6. 126MO HER2DX and pathological complete response in HER2-positive breast cancer: A combined analysis of 4 neoadjuvant studies
7. 234P Real-world treatment patterns and outcomes of patients receiving palbociclib plus endocrine therapy in Spain: Subgroup analysis based on age, sites and number of metastatic locations, menopausal status and dose received from PALBOSPAIN study
8. 218P Characteristics and outcomes of HER2-low (H-Low) and HER2-zero (H-0) advanced breast cancer (ABC) patients (pts) from GEICAM/2014-03 (RegistEM) registry
9. 114P Retrospective analysis to validate the CTS5 in patients from El Álamo IV registry and GEICAM adjuvant studies
10. Generation and molecular characterization of a monoclonal antibody reactive with conserved epitope in sphingomyelinases D from Loxosceles spider venoms
11. 216P Relationship between regulatory T lymphocytes (Treg): Related genes and pathological response to neoadjuvant docetaxel-carboplatin in early-stage triple-negative breast cancer (TNBC)
12. 281P Prevalence of HER2-low breast cancer in the GEICAM/2011-06 trial: Agreement in HER2-low classification between standardized immunohistochemistry assays
13. 261P Subtyping of residual disease (RD) following neoadjuvant chemotherapy (NACT) for triple negative breast cancer (TNBC): Evolution and prognostic impact
14. 258P Correlation between pathological complete response (pCR) following neoadjuvant docetaxel, carboplatin and trastuzumab (TCH) with or without pertuzumab (TCHP) and PAM50 subtypes in HER2(+) early breast cancer (eBC)
15. P2.16-02 Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-Stage Small Cell Lung Cancer: PEERS Phase 2 Trial
16. 233P Germline genetic testing before formal counseling: Impact in cancer management in a Spanish university hospital
17. 406P Phase Ib safety and efficacy of nadunolimab/gemcitabine/carboplatin in mTNBC
18. 356P Prognostic value of the residual cancer burden after neoadjuvant chemotherapy for invasive lobular breast cancer: An international pooled cohort study
19. 141MO Pathological response and early survival data according to TNBCtype4 classifier in operable triple-negative breast cancer (TNBC) treated with neoadjuvant carboplatin and docetaxel
20. 85P Correlation between nCOUNTER PAM-50 assay and three IHC-based surrogate intrinsic breast cancer subtype classifiers: A real-world study
21. 62P Outcomes of high-risk breast cancer (BC) patients from El Álamo IV registry and GEICAM adjuvant clinical trials
22. TDS study of deuterium distribution in 3$^{rd}$ generation high strength steels as a function of charging conditions and cold rolling
23. Hydrogen distribution in 3rd generation high strength steels and its effect on mechanical properties
24. Hydrogen distribution in a MnAl high strength steel and its effect on mechanical properties
25. 53P - Activity of chemotherapy drugs in patient-derived xenografts (PDXs) from chemotherapy naïve local-regional triple negative breast cancer (LR-TNBC) patients
26. Deformation substructure of austenite evaluated by crystallographic reconstruction and its influence on microstructure inheritance in low carbon steels
27. Variación patogénica y fuentes de resistencia a Colletotrichum lindemuthianum Sacc & magn Scrib., patógeno de la antracnosis del frijol, en Colombia Variación patogénica y fuentes de resistencia a Colletotrichum lindemuthianum (Sacc & Magn) Scrib., patógeno de la antracnosis del fríjol, en Colombia
28. 942 - The chemokine IP10 (CXCL10) dominates the long-term immune response stimulated by BCG treatment of non-muscle invasive bladder cancer, but a high concentration of IP10 in urine is strongly indicative of risk for the development of intolerance to BCG
29. Bidirectional light-induced conductance switching in molecular wires containing a dimethyldihydropyrene unit.
30. Toughness and ductility improvement in complex microstructure HSS by means of microstructural parameters optimization (MISTRETO)
31. LBA20 - Safety and immunobiological activity of intratumoral (IT) double-stranded RNA (dsRNA) BO-112 in solid malignancies: First in human clinical trial
32. 408P - Validation of the Royal Marsden Hospital (RMH) prognostic score on an enriched early treatment line cohort for phase I trial patients
33. 186P - Breast cancer PAM50 subtypes: Correlation between RNA-Seq and multiplexed gene expression platforms
34. Electrochemical control of the switching process of photochromic dimethyldihydropyrene derivatives.
35. Self-assembled dimethyldihydropyrene-pyridyl substituted ligands with zinc(ii) meso-tetraphenylporphyrin via axial coordination.
36. 30 CD56 bright natural killer cells primed by innate immune cytokines dominate the immune response stimulated by BCG to non-muscle invasive bladder cancer
37. Heart Rate Variability: a Follow-up in Elite Soccer Players Throughout the Season.
38. Effects of Eccentric Overload Bout on Change of Direction and Performance in Soccer Players.
39. 402 Characterization of Natural Killer cell response to BCG in non-muscle invasive bladder cancer
40. Cerebrospinal Aβ11-x and 17-x levels as indicators of mild cognitive impairment and patients' stratification in Alzheimer's disease.
41. Interstitial pneumonitis and lung fibrosis during adjuvant treatment of melanoma with interferon alpha according to the Kirkwood schedule.
42. PO56 Prevalence of early menopause/secondary amenorrhea in premenopausal women diagnosed with early breast cancer who received adjuvant or neoadjuvant treatment based on docetaxel
43. PP121-M0N NUTRITIONAL ASSESSMENT IN NON-CRITICALLY ILL PATIENTS TREATED WITH TOTAL PARENTERAL NUTRITION
44. PP103-SUN RELATIONSHIP BETWEEN THE DOSE OF INTRAVENOUS FATTY ACIDS AND LIVER FUNCTION TESTS ALTERATION
45. A Combined Top-Down/Bottom-Up Approach for the Nanoscale Patterning of Spin-Crossover Coordination Polymers.
46. Inside Front Cover: A Combined Top-Down/Bottom-Up Approach for the Nanoscale Patterning of Spin-Crossover Coordination Polymers (Adv. Mater. 16/2007).
47. Mapping the Extended Ground State Reactivity Landscape of a Photoswitchable Molecule at a Single Molecular Level.
48. Electron-Transfer-Induced Structural Modification in a Thermochromic Hofmann Clathrate Derivative.
49. Ablation of FAS confers allogeneic CD3 - CAR T cells with resistance to rejection by T cells and natural killer cells.
50. Hofmann Clathrates: A "Blue Box" Approach to Modulate Spin-Crossover Properties.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.